Literature DB >> 22997233

Previously transmitted HIV-1 strains are preferentially selected during subsequent sexual transmissions.

Andrew D Redd1, Aleisha N Collinson-Streng, Nikolaos Chatziandreou, Caroline E Mullis, Oliver Laeyendecker, Craig Martens, Stacy Ricklefs, Noah Kiwanuka, Phyu Hninn Nyein, Tom Lutalo, Mary K Grabowski, Xiangrong Kong, Jordyn Manucci, Nelson Sewankambo, Maria J Wawer, Ronald H Gray, Stephen F Porcella, Anthony S Fauci, Manish Sagar, David Serwadda, Thomas C Quinn.   

Abstract

BACKGROUND: A genetic bottleneck is known to exist for human immunodeficiency virus (HIV) at the point of sexual transmission. However, the nature of this bottleneck and its effect on viral diversity over time is unclear.
METHODS: Interhost and intrahost HIV diversity was analyzed in a stable population in Rakai, Uganda, from 1994 to 2002. HIV-1 envelope sequences from both individuals in initially HIV-discordant relationships in which transmission occurred later were examined using Sanger sequencing of bulk polymerase chain reaction (PCR) products (for 22 couples), clonal analysis (for 3), and next-generation deep sequencing (for 9).
RESULTS: Intrahost viral diversity was significantly higher than changes in interhost diversity (P < .01). The majority of HIV-1-discordant couples examined via bulk PCR (16 of 22 couples), clonal analysis (3 of 3), and next-generation deep sequencing (6 of 9) demonstrated that the viral populations present in the newly infected recipient were more closely related to the donor partner's HIV-1 variants found earlier during infection as compared to those circulating near the estimated time of transmission (P = .03).
CONCLUSIONS: These findings suggest that sexual transmission constrains viral diversity at the population level, partially because of the preferential transmission of ancestral as opposed to contemporary strains circulating in the transmitting partner. Future successful vaccine strategies may need to target these transmitted ancestral strains.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22997233      PMCID: PMC3466994          DOI: 10.1093/infdis/jis503

Source DB:  PubMed          Journal:  J Infect Dis        ISSN: 0022-1899            Impact factor:   5.226


  38 in total

1.  Sex and the genetic diversity of HIV-1.

Authors:  S C Ray; T C Quinn
Journal:  Nat Med       Date:  2000-01       Impact factor: 53.440

2.  Predominance of HIV type 1 subtype G among commercial sex workers from Kinshasa, Democratic Republic of Congo.

Authors:  C Yang; B Dash; S L Hanna; H S Frances; N Nzilambi; R C Colebunders; M St Louis; T C Quinn; T M Folks; R B Lal
Journal:  AIDS Res Hum Retroviruses       Date:  2001-03-01       Impact factor: 2.205

Review 3.  The causes and consequences of HIV evolution.

Authors:  Andrew Rambaut; David Posada; Keith A Crandall; Edward C Holmes
Journal:  Nat Rev Genet       Date:  2004-01       Impact factor: 53.242

4.  Envelope-constrained neutralization-sensitive HIV-1 after heterosexual transmission.

Authors:  Cynthia A Derdeyn; Julie M Decker; Frederic Bibollet-Ruche; John L Mokili; Mark Muldoon; Scott A Denham; Marintha L Heil; Francis Kasolo; Rosemary Musonda; Beatrice H Hahn; George M Shaw; Bette T Korber; Susan Allen; Eric Hunter
Journal:  Science       Date:  2004-03-26       Impact factor: 47.728

5.  Transmission of the X4 phenotype of HIV-1: is there evidence against the "random transmission" hypothesis?

Authors:  Charlotte Hedskog; Mattias Mild; Jan Albert
Journal:  J Infect Dis       Date:  2011-12-05       Impact factor: 5.226

6.  Detection of diverse variants of human immunodeficiency virus-1 groups M, N, and O and simian immunodeficiency viruses from chimpanzees by using generic pol and env primer pairs.

Authors:  C Yang; B C Dash; F Simon; G van der Groen; D Pieniazek; F Gao; B H Hahn; R B Lal
Journal:  J Infect Dis       Date:  2000-05-15       Impact factor: 5.226

7.  Selective transmission of human immunodeficiency virus type-1 variants from mothers to infants.

Authors:  S M Wolinsky; C M Wike; B T Korber; C Hutto; W P Parks; L L Rosenblum; K J Kunstman; M R Furtado; J L Muñoz
Journal:  Science       Date:  1992-02-28       Impact factor: 47.728

8.  Genotypic and phenotypic characterization of HIV-1 patients with primary infection.

Authors:  T Zhu; H Mo; N Wang; D S Nam; Y Cao; R A Koup; D D Ho
Journal:  Science       Date:  1993-08-27       Impact factor: 47.728

9.  Identification of modifiable factors that affect the genetic diversity of the transmitted HIV-1 population.

Authors:  Manish Sagar; Ludo Lavreys; Jared M Baeten; Barbra A Richardson; Kishorchandra Mandaliya; Jeckoniah O Ndinya-Achola; Joan K Kreiss; Julie Overbaugh
Journal:  AIDS       Date:  2004-03-05       Impact factor: 4.177

10.  Increasing antigenic and genetic diversity of the V3 variable domain of the human immunodeficiency virus envelope protein in the course of the AIDS epidemic.

Authors:  C L Kuiken; G Zwart; E Baan; R A Coutinho; J A van den Hoek; J Goudsmit
Journal:  Proc Natl Acad Sci U S A       Date:  1993-10-01       Impact factor: 11.205

View more
  45 in total

1.  Sensitivity to Broadly Neutralizing Antibodies of Recently Transmitted HIV-1 Clade CRF02_AG Viruses with a Focus on Evolution over Time.

Authors:  Karl Stefic; Mélanie Bouvin-Pley; Asma Essat; Clara Visdeloup; Alain Moreau; Cécile Goujard; Marie-Laure Chaix; Martine Braibant; Laurence Meyer; Francis Barin
Journal:  J Virol       Date:  2019-01-04       Impact factor: 5.103

2.  Evolution of the Envelope Glycoprotein of HIV-1 Clade B toward Higher Infectious Properties over the Course of the Epidemic.

Authors:  Laurence Meyer; Francis Barin; Mélanie Bouvin-Pley; Maxime Beretta; Alain Moreau; Emmanuelle Roch; Asma Essat; Cécile Goujard; Marie-Laure Chaix; Nathalie Moiré; Loïc Martin; Martine Braibant
Journal:  J Virol       Date:  2019-03-05       Impact factor: 5.103

3.  Novel HIV vaccine strategies: overview and perspective.

Authors:  Yehuda Z Cohen; Raphael Dolin
Journal:  Ther Adv Vaccines       Date:  2013-09

4.  Phylogenetic relatedness of HIV-1 donor and recipient populations.

Authors:  Joel O Wertheim; Konrad Scheffler; Jun Yong Choi; Davey M Smith; Sergei L Kosakovsky Pond
Journal:  J Infect Dis       Date:  2013-01-11       Impact factor: 5.226

5.  Reply to Wertheim et al.

Authors:  Andrew D Redd; Thomas C Quinn
Journal:  J Infect Dis       Date:  2013-01-11       Impact factor: 5.226

6.  Drift of the HIV-1 envelope glycoprotein gp120 toward increased neutralization resistance over the course of the epidemic: a comprehensive study using the most potent and broadly neutralizing monoclonal antibodies.

Authors:  M Bouvin-Pley; M Morgand; L Meyer; C Goujard; A Moreau; H Mouquet; M Nussenzweig; C Pace; D Ho; P J Bjorkman; D Baty; P Chames; M Pancera; P D Kwong; P Poignard; F Barin; M Braibant
Journal:  J Virol       Date:  2014-09-17       Impact factor: 5.103

7.  New insights into the evolutionary rate of hepatitis B virus at different biological scales.

Authors:  You-Yu Lin; Chieh Liu; Wei-Hung Chien; Li-Ling Wu; Yong Tao; Dafei Wu; Xuemei Lu; Chia-Hung Hsieh; Pei-Jer Chen; Hurng-Yi Wang; Jia-Horng Kao; Ding-Shinn Chen
Journal:  J Virol       Date:  2015-01-14       Impact factor: 5.103

Review 8.  Molecular tools for studying HIV transmission in sexual networks.

Authors:  Mary K Grabowski; Andrew D Redd
Journal:  Curr Opin HIV AIDS       Date:  2014-03       Impact factor: 4.283

9.  Targeted deep sequencing of HIV-1 using the IonTorrentPGM platform.

Authors:  Gustavo H Kijak; Eric Sanders-Buell; Elizabeth A Harbolick; Phuc Pham; Agnes L Chenine; Leigh Anne Eller; Kathleen Rono; Merlin L Robb; Nelson L Michael; Jerome H Kim; Sodsai Tovanabutra
Journal:  J Virol Methods       Date:  2014-05-04       Impact factor: 2.014

10.  Homogenous HIV-1 subtype B quasispecies in Brazilian men and women recently infected via heterosexual transmission.

Authors:  Nancy Lima Gouveia; Michelle Camargo; Marcos Montani Caseiro; Luiz Mario Ramos Janini; Maria Cecilia Araripe Sucupira; Ricardo Sobhie Diaz
Journal:  Virus Genes       Date:  2014-02-14       Impact factor: 2.332

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.